Femasys Inc (NASDAQ:FEMY)
| Market Cap | 8.55M-60.6% |
| Revenue (ttm) | 2.30M+21.9% |
| Net Income | -12.29M+41.5% |
| EPS | -4.57+73.1% |
| Shares Out | 3.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 46,055 |
| Open | 2.71 |
| Previous Close | 2.68 |
| Day's Range | 2.71 - 2.83 |
| 52-Week Range | 2.02 - 22.20 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Nov 17, 2026 |
About FEMY
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer. Additionally, the company markets its FemVue saline-air device across various international regions, including the U.S., Europe, Canada, and Japan. Its infertility-related products are supplied to obstetrician-gynecologists, other allied healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. The company also offers a range of non-surgical product technologies.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$FEMY stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in FEMY holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by FEMY's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
FEMY Estimated quarterly lobbying spending
Source: U.S. Senate LDA
FEMY Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New FEMY patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to FEMY from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in FEMY
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $98.09K |
| VXFVanguard Extended Market ETF | $79.90K |
Estimated from each fund’s disclosed top holdings × AUM
FEMY Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from FEMY’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score